The largest database of trusted experimental protocols

Dxc 800 analyzer

Manufactured by Beckman Coulter
Sourced in United States, Canada

The DXC 800 analyzer is a clinical chemistry and immunoassay instrument designed for in vitro diagnostic testing. It is capable of performing a variety of routine and specialized clinical chemistry and immunoassay tests on a wide range of sample types. The instrument is designed for use in medical laboratories and hospitals.

Automatically generated - may contain errors

8 protocols using dxc 800 analyzer

1

Serum Biomarkers Measurement Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, and fasting glucose, total cholesterol, high-density lipoprotein (HDL)-cholesterol and triglyceride levels were determined using commercial enzymatic kits on a DxC800 analyzer (Beckman-Coulter, Villepinte, France).
+ Open protocol
+ Expand
2

Serum Biomarkers for Disease Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum concentrations of alanine aminotransferase (ALT) and aspartate Aminotransferase (AST) were measured with a Beckman DXC 800 analyzer (Beckman, Brea, CA, USA). Serum concentration of interleukin-6 (IL-6), interleukin-17A (IL-17A), monocyte chemoattractant protein 1 (MCP-1), chemokine growth-regulated protein (GRO)-alpha, transforming growth factor beta (TGF- β ) and adiponectin were measured with ELISA kits (Abcam, Cambridge, UK).
+ Open protocol
+ Expand
3

Chronic Kidney Disease Diagnostic Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, using the US National Kidney Foundation Kidney Disease Outcome Quality Initiative (KDOQI) Working Group definition (National Kidney F, 2002 (link)). eGFR was estimated from the serum creatinine concentration (eGFR) (Levey et al., 2009 (link)) using the CKD Epidemiology Collaboration (CKD-EPI) equation. Severity of CKD was defined by eGFR categories: ≥ 60 (stage 1 and 2), 30–59 (stage 3), 29–15 (stage 4) and < 15 (stage 5)ml/min/1.73 m2 (National Kidney F, 2002 (link)). Creatinine concentrations were measured by the Jaffe method on the Beckman DXC800 analyzer. The creatinine assay was calibrated to the isotope Dilution Mass Spectroscopy (IDMS) method using the National Institute of Standards and Technology (NIST) Reference material.
+ Open protocol
+ Expand
4

Plasma Biomarkers of Coronary Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous blood was drawn from all individuals after a 12 h overnight fast prior to coronary angiography and was centrifuged immediately at 3000 r/min and 4°C for 10 min. Plasma specimens were then collected and stored at −80°C until further analysis. All specimens were analyzed at the same time to control for testing variability. Plasma AAT and high-sensitivity C-reactive protein (hsCRP) levels were measured by immunoturbidimetry[10 (link)] using an IMMAGE 800 immunochemistry system (Beckman Coulter, USA). The AAT reagent (447740, Beckman Coulter, USA) and hsCRP reagent (474630, Beckman Coulter, USA) were used according to the manufacturer's instructions. Total cholesterol and triglycerides were assayed by routine enzymatic methods (GPO-PAP) using a Beckman DxC800 analyzer (Fullerton, USA). High-density lipoprotein cholesterol (HDL-C) level was measured using a chemical modification and selective melting kit (Kyowa Medex, Tokyo, Japan). The low-density lipoprotein cholesterol (LDL-C) concentration was calculated using the Friedeward equation.[11 (link)] The intra- and inter-assay coefficients of variation for plasma AAT level ranged from 2.1% to 3.1%, and 2.8% to 3.3%, respectively. The AAT level reference range was 88–174 mg/dl.
+ Open protocol
+ Expand
5

Biomarkers of Pathophysiologic Domains

Check if the same lab product or an alternative is used in the 5 most similar protocols
We measured a panel of biomarkers representing four pathophysiologic domains: inflammation, coagulation, oxidative stress and tissue hypoxia. Each domain included a primary marker and up to 2 secondary markers. For inflammation we measured interleukin(IL)-6 (primary), tumor necrosis factor (TNF), and IL-10. For coagulation we measured thrombin-anti-thrombin complex (TAT) (primary) and D-dimers. For oxidative stress we measured urine isoprostane and for tissue hypoxia we measured lactate. We measured IL-6, IL-10, and TNF using an enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN). For D-dimers we used a latex agglutination assay (Diagnostica Stago, Parsippany, NJ) and for TAT we used an ELISA (Siemens Healthcare Diagnostics Products GmbH, Marburg, Germany). We measured isoprostane in the urine using ELISA, (Oxford Biomedical, Oxford, UK) and plasma lactate was analyzed (enzymatic) using a DXC800 analyzer (Beckman Coulter, Brea CA). All assays were performed according to manufacturer specifications.
+ Open protocol
+ Expand
6

Parenchymal Injury Evaluation During Normothermic Machine Perfusion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) were measured in the perfusate every 2 hours during NMP in our clinical laboratory using an enzymatic rate method on a Beckman Coulter DxC 800 analyzer (Beckman Coulter Canada, Ontario Canada). Inflammatory markers included tumor necrosis factor-α (TNF-α) and interleukin 6 (IL-6) levels in the perfusate, which were determined using porcine TNF-alpha and IL-6 ELISA kits (R&D Systems, Minnesota, United States). To further assess parenchymal injury a biopsy was taken at the end of dissection (pre-ischemia), and again at the end of 12 hours NMP. Samples were preserved in 10% formalin for hematoxylin and eosin (H&E) staining. H&E specimens were assessed by a blinded pathologist using light microscopy to assign injury score based on necrosis, hemorrhage, cholestasis and sinusoidal dilatation (Table 2).[13 (link)]
+ Open protocol
+ Expand
7

Comprehensive Metabolic Profiling in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood fasting glucose was checked from tail-vein blood using an automatic glucose monitor (One Touch). Plasma triglycerides, and total cholesterol and liver triglyceride were measured with colorimetric assay kits (Wako, Osaka, Japan). Total liver lipids were extracted with chloroform-methanol (2:1, v/v) mixture according to the Folch method [12 (link)]. Plasma insulin levels were measured with a commercial insulin assay ELISA kit (ALPCO Diagnostics, Salem, NH, USA). Serum levels of alanine aminotransferase (ALT) were determined using a Beckman DXC 800 analyzer (Brea, CA, USA).
+ Open protocol
+ Expand
8

Metabolic Biomarkers in Animal Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood glucose levels were determined with the One Touch II glucose meter (LifeScan). Serum insulin levels were measured with a commercially available enzyme-linked immunosorbent assay (ELISA) (ALPCO, Salem, NH). Serum levels of total and high-molecular-weight (HMW) adiponectin were measured using mouse ELISA kits (ALPCO). Serum levels of tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), and leptin were measured with commercially available ELISA kits (Millipore, Billerica, MA). Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined with the Beckman DXC 800 analyzer (Brea, CA). Hepatic lipid peroxidation was determined using a commercially available kit (Cayman Chemicals, Ann Arbor, MI). Lipid peroxidation was assessed as the amount of thiobarbituric acid reactive substances (TBARS) produced according to manufacturer's instruction.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!